31 October 2025NewsAmericasJohn Cox at Barnes & Thornburg

Is Hatch-Waxman litigation for orphan drugs working?

Rising patent litigation over rare disease treatments highlights the success of the Hatch-Waxman and Orphan Drug Acts, says John Cox at Barnes & Thornburg.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Nomination call: Influential Women in IP list closes ahead of International Women’s Day

6 March 2026 With IWD approaching, WIPR urges practitioners to submit nominations for its Influential Women in IP list, recognising outstanding female leaders across the profession.

Americas

Abbott IP chief: ‘Firms without AI policies scare me’

5 March 2026 The healthcare company’s chief IP counsel is researching how law firms and patent attorneys are using AI tools to inform its own guidelines for external legal providers.

Americas

Moderna inks billion-dollar deal to settle long-running Spikevax dispute

5 March 2026 Moderna settles, agreeing to part with up to $2.25 billion to avoid a trial and secure a licence to continue using the platform underpinning its COVID-19 vaccine.

More features

Nomination call: Influential Women in IP list closes ahead of International Women’s Day

Abbott IP chief: ‘Firms without AI policies scare me’

Moderna inks billion-dollar deal to settle long-running Spikevax dispute

DWT recruits first-chair trial litigator as latest hire in IP expansion

FisherBroyles opens San Diego office

To cite or not to cite: How can we avoid misuse of AI in court?

Gowling WLG brings in transactions expert with UK and US experience

LSPN Awards 2026 finalists revealed

Is Hatch-Waxman litigation for orphan drugs working?

More on this story

Editor's picks

Editor's picks

More features